Improving the Selection of Patients With Glioblastoma Multiforme for Treatment With Epidermal Growth Factor Receptor Inhibitor Therapies

Sponsor and Collaborators     
North Central Cancer Treatment Group
National Cancer Institute (NCI)
 
Contact
Cedar Rapids Oncology Associates     
Cedar Rapids, Iowa, United States, 52403
Contact: Clinical Trials Office – Cedar Rapids Oncology Associates     319-363-2690
        
Mercy Regional Cancer Center at Mercy Medical Center     
Cedar Rapids, Iowa, United States, 52403
Contact: Deborah W. Wilbur     319-398-6011
        
Mercy Cancer Center at Mercy Medical Center – North Iowa     
Mason City, Iowa, United States, 50401
Contact: Clinical Trials Office – Mercy Cancer Center at Mercy Medical     641-422-6304
        
Mercy Medical Center – Sioux City     
Sioux City, Iowa, United States, 51102
Contact: Donald B. Wender, MD, PhD     712-252-0088
        
Siouxland Hematology-Oncology Associates, LLP     
Sioux City, Iowa, United States, 51101
Contact: Donald B. Wender, MD, PhD     712-252-0088
        
St. Luke’s Regional Medical Center     
Sioux City, Iowa, United States,
Contact: Donald B. Wender, MD, PhD     712-252-0088         

Investigators
Jann N. Sarkaria, MD     Mayo Clinic
Paul D. Brown, MD     Mayo Clinic
Joon H. Uhm, MD     Mayo Clinic
Jan C. Buckner, MD     Mayo Clinic


Continue Reading

ClinicalTrials.gov Identifier
NCT00897663